Literature DB >> 692548

Increased absenteeism from work after detection and labeling of hypertensive patients.

R B Haynes, D L Sackett, D W Taylor, E S Gibson, A L Johnson.   

Abstract

A study of hypertension in an industrial setting allowed us to confirm and explore an earlier retrospective finding that the labeling of patients as hypertensive resulted in increased absenteeism from work. After screening and referral, we found that absenteeism rose (mean +/- 1 S.E.) 5.2 +/- 2.3 days per year (P less than 0.025); this 80 per cent increase greatly exceeded the 9 per cent rise in absenteeism in the general employee population during this period. The main factors associated with increased absenteeism were becoming aware of the condition (P less than 0.01) and low compliance with treatment (P less than 0.001). Subsequent absenteeism among patients unaware of their hypertension before screening was not related to the degree of hypertension, whether the worker was started on therapy, the degree of blood-pressure control achieved or exposure to attempts to promote compliance. These results have major implications for hypertension screening programs, especially since absenteeism rose among those previously unaware of their condition, regardless of whether antihypertensive therapy was begun.

Entities:  

Mesh:

Year:  1978        PMID: 692548     DOI: 10.1056/NEJM197810052991403

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  120 in total

1.  Enough guidelines already.

Authors:  S Roedde
Journal:  Can Fam Physician       Date:  1999-03       Impact factor: 3.275

Review 2.  Quality of life with nonpharmacologic treatment of hypertension.

Authors:  J P Roel; C L Hildebrant; R H Grimm
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

3.  The periodic health examination. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  Can Med Assoc J       Date:  1979-11-03       Impact factor: 8.262

4.  Cholesterol and coronary heart disease: screening and treatment.

Authors:  S Ebrahim; G D Smith; C McCabe; N Payne; M Pickin; T A Sheldon; F Lampe; F Sampson; S Ward; G Wannamthee
Journal:  Qual Health Care       Date:  1998-12

5.  The impact of hypertension in the middle years.

Authors:  J R Hilditch
Journal:  Can Fam Physician       Date:  1984-05       Impact factor: 3.275

6.  A young life sadly blighted--the future for clinical academic careers in general practice.

Authors:  Amanda Howe; Yvonne Carter
Journal:  Br J Gen Pract       Date:  2003-05       Impact factor: 5.386

7.  The cholesterol controversy.

Authors:  P Thomas
Journal:  BMJ       Date:  1992-04-04

8.  Indeterminate HIV-1 western blots: implications and considerations for widespread HIV testing.

Authors:  C L Celum; R W Coombs
Journal:  J Gen Intern Med       Date:  1992 Nov-Dec       Impact factor: 5.128

9.  Assessment of quality of life in the treatment of hypertension.

Authors:  J S Callender
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

10.  On redefining hypertension.

Authors:  Michel Accad; Herbert L Fred
Journal:  Tex Heart Inst J       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.